Eagle Pharmaceuticals Inc
(EGRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2013 | 12-2012 | 09-2012 | 12-2011 | 09-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,048 | N/A | -19,383 | N/A | 0 |
| Depreciation Amortization | 1,322 | 470 | 477 | N/A | 0 |
| Accounts receivable | -3,543 | N/A | -1,320 | N/A | 0 |
| Accounts payable and accrued liabilities | -251 | N/A | -93 | N/A | 0 |
| Other Working Capital | -2,831 | 2,810 | 2,815 | N/A | N/A |
| Other Operating Activity | 5,472 | 540 | 1,956 | 0 | 0 |
| Operating Cash Flow | $-5,879 | $3,820 | $-15,548 | $N/A | $0 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,500 | N/A | 3,000 | N/A | 0 |
| PPE Investments | -41 | -30 | -33 | N/A | 0 |
| Other Investing Activity | 0 | 3,000 | 0 | 0 | 0 |
| Investing Cash Flow | $1,459 | $2,970 | $2,967 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 9,663 | N/A | 0 |
| Other Financing Activity | 9,809 | 9,660 | -115 | 0 | 0 |
| Financing Cash Flow | $9,809 | $9,660 | $9,548 | $N/A | $0 |
| Beginning Cash Position | 5,067 | N/A | 8,100 | N/A | 0 |
| End Cash Position | 10,456 | N/A | 5,067 | N/A | 0 |
| Net Cash Flow | $5,389 | $16,450 | $-3,033 | $N/A | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,879 | 3,820 | -15,548 | N/A | 0 |
| Capital Expenditure | -41 | N/A | -33 | N/A | 0 |
| Free Cash Flow | -5,920 | 3,820 | -15,581 | 0 | 0 |